WO2025083561 - NOVEL LEAD SMALL MOLECULE INHIBITORS ON UNDRUGGABLE TARGET TOWARDS ANTICANCER ACTIVITY
National phase entry is expected:
Publication Number
WO/2025/083561
Publication Date
24.04.2025
International Application No.
PCT/IB2024/060117
International Filing Date
16.10.2024
Title **
[English]
NOVEL LEAD SMALL MOLECULE INHIBITORS ON UNDRUGGABLE TARGET TOWARDS ANTICANCER ACTIVITY
[French]
NOUVEAUX INHIBITEURS À PETITES MOLÉCULES DE PLOMB SUR UNE CIBLE INTRAITABLE VIS-À-VIS DE L'ACTIVITÉ ANTICANCÉREUSE
Applicants **
PILLAI UNIVERSAL LLC
PILLAI, DR. BASKARAN
DR. M.G., Dinesh
Inventors
PILLAI, DR. BASKARAN
DR. M.G., Dinesh
Priority Data
202341028319
18.10.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter II
* |
| * | |
| * | |
| * | |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2229 | |
| EPO | Filing, Examination, Granting | 12490 | |
| Japan | Filing, Examination, Granting | 2203 | |
| South Korea | Filing, Examination, Granting | 2167 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
24,429
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention discloses a novel Lead small molecule inhibitors on undruggable target towards anticancer activity The novel anti-cancer molecules comprises of structures in accordance with Formula 1 or any derivative thereof, pharmaceutically acceptable salt thereof, or combination thereof in which: R is unsubstituted/amino, oxo, hydroxyl substituted, straight/branched chain saturated/unsaturated, hydrocarbon group X is oxo or imino group Y is hydrogen, saturated/unsaturated hydrocarbon, oxo substituted nitrogen containing group[French]
La présente invention concerne de nouveaux inhibiteurs à petites molécules de plomb sur une cible intraitable vis-à-vis de l'activité anticancéreuse, les nouvelles molécules anticancéreuses comprenant des structures selon la formule 1 ou un dérivé quelconque de celles-ci, un sel pharmaceutiquement acceptable de celles-ci, ou une combinaison de celles-ci. R étant un groupe hydrocarboné non substitué/amino, oxo, hydroxyle substitué, saturé/insaturé à chaîne droite/ramifiée, X étant un groupe oxo ou imino, Y étant hydrogène, un groupe hydrocarboné saturé/insaturé, un groupe contenant de l'azote substitué par un oxo.